Infant Bacterial Therapeutics AB (IFTBF)
6.18
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Infant Bacterial Therapeutics EPS Diluted (Quarterly) : -0.1863 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Orexo AB | -0.417 |
| Swedencare AB | 0.0121 |
| Camurus AB | 0.263 |
| Moberg Pharma AB | -0.003 |
| AstraZeneca PLC | 0.9849 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.509M |
| Total Expenses (Quarterly) | 2.509M |
| Enterprise Value | 69.40M |
| Earnings Yield | -9.12% |
| Normalized Earnings Yield | -9.116 |